lotriderm cream
necessity supplies ltd - clotrimazole; betamethasone dipropionate - cutaneous cream - 10mg/1gram ; 640microgram/1gram
tricoderm ointment
winwa medical sdn. bhd. - triamcinolone acetonide; econazole nitrate -
triderm- triamcinolone acetonide cream
crown laboratories - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 5 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hpa axis suppression and cushing’s syndrome than mature patients because of a larger skin surface area to body weight ratio. hypothalamic-pituitary-adrenai (hpa) axis suppression, cushing’s syndrome, and intracranial hypertension have been reported in pediatric patients receiving topical corticosteroids. manifestations of adrenal suppression in pediatric patients include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to acth stimulation. manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. administration of topical cortico
sentinel
agrimm technologies ltd - trichoderma atroviride (strain lu132) - trichoderma atroviride (strain lu132) 2.5 b cfu/g - fungicide
tenet
agrimm technologies ltd - trichoderma atroviride (strain lu132) - trichoderma atroviride (strain lu132) 5 m cfu/g - fungicide
lotriderm cream
organon canada inc. - betamethasone (betamethasone dipropionate); clotrimazole - cream - 0.05%; 1% - betamethasone (betamethasone dipropionate) 0.05%; clotrimazole 1% - anti-inflammatory agents
triderma- hydroquinone, tretinoin, fluocinolone acetonide cream
pella pharmaceutical co. ltd - tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m), hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - triderma is indicated for the short-term intermittent treatment of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens. triderma is contraindicated in individuals with a history of hypersensitivity, allergy, or intolerance to this product or any of its components.
trigoderm gel 0.5 % w/w fusidic acid, 0.1 % w/w betamethasone
dechra veterinary products a/s - fusidic acid, betamethasone valerate - gel - 0.5/0.1 %w/w - betamethasone and antibiotics - canine - antibacterial
trigoderm gel 0.5% w/w fusidic acid, 0.1% w/w betamethasone
dechra veterinary products a/s - betamethasone, fusidic acid - gel - antimicrobial; anti inflammatory - dogs
triderm
schering-plough labo n.v. - betamethasone (betamethasone dipropionate), clotrimazole, gentamicin (gentamicin sulfate) - cream - 0,5mg/g+10mg/g+1mg/g